Molecular Therapy: Difference between revisions
Content deleted Content added
Adding infobox journal with (infoboxJournal.js) |
|||
Line 1: | Line 1: | ||
{{distinguish|Molecular medicine|Auger therapy}} |
{{distinguish|Molecular medicine|Auger therapy}} |
||
{{Infobox journal |
|||
| title = Molecular Therapy |
|||
⚫ | |||
| image = <!-- or |cover= --> |
|||
| image_size = |
|||
| alt = |
|||
| caption = |
|||
| former_name = <!-- or |former_names= --> |
|||
| abbreviation = <!-- ISO 4 abbreviation --> |
|||
| bluebook = <!-- For law journals only --> |
|||
| mathscinet = <!-- For the MathSciNet abbreviation IF different from ISO 4 abbreviation--> |
|||
| nlm = <!-- For the NLM abbreviation IF different from ISO 4 abbreviation--> |
|||
| discipline = <!-- or |subject= --> |
|||
| peer-reviewed = |
|||
| language = |
|||
| editor = <!-- or |editors= --> |
|||
| publisher = [[Elsevier]] |
|||
| country = |
|||
| history = |
|||
| frequency = |
|||
| openaccess = |
|||
| license = |
|||
| impact = |
|||
| impact-year = |
|||
| ISSNlabel = |
|||
| ISSN = |
|||
| eISSN = |
|||
| CODEN = |
|||
| JSTOR = |
|||
| LCCN = |
|||
| OCLC = |
|||
| website = https://www.journals.elsevier.com/molecular-therapy |
|||
| link1 = |
|||
| link1-name = |
|||
| link2 = <!-- up to |link5= --> |
|||
| link2-name = <!-- up to |link5-name= --> |
|||
}} |
|||
⚫ | |||
The founder of the journal and its Editor-in-Chief in the first five years was [[Inder Verma]].<ref>https://www.salk.edu/news-release/salk-scientist-inder-verma-to-receive-2009-outstanding-achievement-award-from-american-society-of-gene-therapy/</ref> |
The founder of the journal and its Editor-in-Chief in the first five years was [[Inder Verma]].<ref>https://www.salk.edu/news-release/salk-scientist-inder-verma-to-receive-2009-outstanding-achievement-award-from-american-society-of-gene-therapy/</ref> |
Revision as of 13:02, 16 August 2019
Language | English |
---|---|
Publication details | |
Publisher | |
ISO 4 | Find out here |
Links | |
Molecular Therapy is a scientific journal, published by Elsevier, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".[1]
The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma.[2]
References
External links